Staged or Simultaneous Surgery for Colon or Rectal Cancer with Synchronous Liver Metastases: Implications for Study Design and Clinical Endpoints

Sheraz Yaqub, Georgios Antonios Margonis, Kjetil Søreide, Sheraz Yaqub, Georgios Antonios Margonis, Kjetil Søreide

Abstract

In patients presenting with colorectal cancer and synchronous liver metastases, the disease burden related to the liver metastasis is the driving cause of limited longevity and, eventually, risk of death. Surgical resection is the potentially curative treatment for colorectal cancer liver metastases. In the synchronous setting where both the liver metastases and the primary tumor are resectable with a relative low risk, the oncological surgeon and the patient may consider three potential treatment strategies. Firstly, a "staged" or a "simultaneous" surgical approach. Secondly, for a staged strategy, a 'conventional approach' will suggest removal of the primary tumor first (either colon or rectal cancer) and plan for liver surgery after recovery from the first operation. A "Liver first" strategy is prioritizing the liver resection before resection of the primary tumor. Planning a surgical trial investigating a two-organ oncological resection with highly variable extent and complexity of resection as well as the potential impact of perioperative chemo(radio)therapy makes it difficult to find the optimal primary endpoint. Here, we suggest running investigational trials with carefully chosen composite endpoints as well as embedded risk-stratification strategies to identify subgroups of patients who may benefit from simultaneous surgery.

Keywords: clinical endpoints; colorectal cancer; liver metastases; simultaneous surgery; staged surgery.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic overview of different approaches for patients with colorectal cancer with synchronous liver metastases and clinical endpoints.
Figure 2
Figure 2
The IDEAL framework.

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660.
    1. Siriwardena A.K., Mason J.M., Mullamitha S., Hancock H.C., Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat. Rev. Clin. Oncol. 2014;11:446–459. doi: 10.1038/nrclinonc.2014.90.
    1. Curley S.A. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin. Oncol. 2005;32((Suppl. S9)):S109–S111. doi: 10.1053/j.seminoncol.2005.06.011.
    1. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann. Surg. 1999;230:309–318. doi: 10.1097/00000658-199909000-00004.
    1. Scherman P., Syk I., Holmberg E., Naredi P., Rizell M. Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study. Eur. J. Surg. Oncol. 2021;47:375–383. doi: 10.1016/j.ejso.2020.07.030.
    1. Adam R., De Gramont A., Figueras J., Kokudo N., Kunstlinger F., Loyer E., Poston G., Rougier P., Rubbia-Brandt L., Sobrero A., et al. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus. Cancer Treat. Rev. 2015;41:729–741. doi: 10.1016/j.ctrv.2015.06.006.
    1. Cervantes A., Adam R., Rosello S., Arnold D., Normanno N., Taieb J., Seligmann J., De Baere T., Osterlund P., Yoshino T., et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 2022;34:10–32. doi: 10.1016/j.annonc.2022.10.003.
    1. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Version 3. [(accessed on 8 February 2023)]. Available online: .
    1. Zeyara A., Toren W., Soreide K., Andersson R. The liver-first approach for synchronous colorectal liver metastases: A systematic review and meta-analysis of completion rates and effects on survival. Scand. J. Surg. 2022;111:14574969211030131. doi: 10.1177/14574969211030131.
    1. Labori K.J., Guren M.G., Brudvik K.W., Rosok B.I., Waage A., Nesbakken A., Larsen S., Dueland S., Edwin B., Bjornbeth B.A. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: Short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal. Dis. 2017;19:731–738. doi: 10.1111/codi.13622.
    1. Giuliante F., Vigano L., De Rose A.M., Mirza D.F., Lapointe R., Kaiser G., Barroso E., Ferrero A., Isoniemi H., Lopez-Ben S., et al. Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry. Ann. Surg. Oncol. 2021;28:8198–8208. doi: 10.1245/s10434-021-10220-w.
    1. Gumiero J.L., Oliveira B.M.S., Neto P.A.O., Pandini R.V., Gerbasi L.S., Figueiredo M.N., Kruger J.A.P., Seid V.E., Araujo S.E.A., Tustumi F. Timing of resection of synchronous colorectal liver metastasis: A systematic review and meta-analysis. J. Surg. Oncol. 2022;126:175–188. doi: 10.1002/jso.26868.
    1. Siriwardena A.K. Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone? Br. J. Surg. 2022;109:303–305. doi: 10.1093/bjs/znab457.
    1. Rocca A., Cipriani F., Belli G., Berti S., Boggi U., Bottino V., Cillo U., Cescon M., Cimino M., Corcione F., et al. The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology. Updates Surg. 2021;73:1247–1265. doi: 10.1007/s13304-021-01100-9.
    1. Zhou J., Feng L., Li X., Wang M., Zhao Y., Zhang N., Wang L., Zhang T., Mao A., Xu Y., et al. The Value of Laparoscopic Simultaneous Colorectal and Hepatic Resection for Synchronous Colorectal Cancer Liver Metastasis: A Propensity Score Matching Study. Front. Oncol. 2022;12:916455. doi: 10.3389/fonc.2022.916455.
    1. Wu Y., Mao A., Wang H., Fang G., Zhou J., He X., Cai S., Wang L. Association of Simultaneous vs Delayed Resection of Liver Metastasis with Complications and Survival among Adults with Colorectal Cancer. JAMA Netw. Open. 2022;5:e2231956. doi: 10.1001/jamanetworkopen.2022.31956.
    1. Kazi M., Patkar S., Patel P., Kunte A., Desouza A., Saklani A., Goel M. Simultaneous resection of synchronous colorectal liver metastasis: Feasibility and development of a prediction model. Ann. Hepatobiliary Pancreat. Surg. 2022;27:40–48. doi: 10.14701/ahbps.22-043.
    1. Boudjema K., Locher C., Sabbagh C., Ortega-Deballon P., Heyd B., Bachellier P., Metairie S., Paye F., Bourlier P., Adam R., et al. Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial. Ann. Surg. 2021;273:49–56. doi: 10.1097/SLA.0000000000003848.
    1. Chan A.K.C., Mason J.M., Baltatzis M., Siriwardena A.K., Co S.C. Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC) Ann. Surg. Oncol. 2022;29:1939–1951. doi: 10.1245/s10434-021-11017-7.
    1. Carbone F., Chee Y., Rasheed S., Cunningham D., Bhogal R.H., Jiao L., Tekkis P., Kontovounisios C. Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach. Updates Surg. 2022;74:451–465. doi: 10.1007/s13304-021-01234-w.
    1. Kleive D., Aas E., Angelsen J.H., Bringeland E.A., Nesbakken A., Nymo L.S., Schultz J.K., Soreide K., Yaqub S. Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps. Oncol. Ther. 2021;9:111–120. doi: 10.1007/s40487-021-00148-2.
    1. Krul M.F., Elfrink A.K.E., Buis C.I., Swijnenburg R.J., Te Riele W.W., Verhoef C., Gobardhan P.D., Dulk M.D., Liem M.S.L., Tanis P.J., et al. Hospital variation and outcomes of simultaneous resection of primary colorectal tumour and liver metastases: A population-based study. HPB. 2022;24:255–266. doi: 10.1016/j.hpb.2021.06.422.
    1. Shubert C.R., Habermann E.B., Bergquist J.R., Thiels C.A., Thomsen K.M., Kremers W.K., Kendrick M.L., Cima R.R., Nagorney D.M. A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection. J. Gastrointest. Surg. 2015;19:1982–1994. doi: 10.1007/s11605-015-2895-z.
    1. Driedger M.R., Yamashita T.S., Starlinger P., Mathis K.L., Smoot R.L., Cleary S.P., Nagorney D.M. Synchronous resection of colorectal cancer primary and liver metastases: An outcomes analysis. HPB. 2021;23:1277–1284. doi: 10.1016/j.hpb.2021.01.002.
    1. Dimick J.B., Sedrakyan A., McCulloch P. The IDEAL Framework for Evaluating Surgical Innovation: How It Can Be Used to Improve the Quality of Evidence. JAMA Surg. 2019;154:685–686. doi: 10.1001/jamasurg.2019.0903.
    1. Kazaryan A.M., Rosok B.I., Edwin B. Morbidity assessment in surgery: Refinement proposal based on a concept of perioperative adverse events. ISRN Surg. 2013;2013:625093. doi: 10.1155/2013/625093.
    1. Tajiri T., Hayashi H., Miyamoto Y., Imai K., Kitano Y., Kaida T., Sawayama H., Beppu T., Yamashita Y.I., Baba H. Clinical Impact of Operative Order in Laparoscopic Simultaneous Resection for Synchronous Colorectal Liver Metastases. Cancer Diagn. Progn. 2021;1:151–156. doi: 10.21873/cdp.10020.
    1. Ono Y., Saiura A., Arita J., Takahashi Y., Takahashi M., Inoue Y. Short-Term Outcomes after Simultaneous Colorectal and Major Hepatic Resection for Synchronous Colorectal Liver Metastases. Dig. Surg. 2017;34:447–454. doi: 10.1159/000455295.
    1. De Graaff M.R., Elfrink A.K.E., Buis C.I., Swijnenburg R.J., Erdmann J.I., Kazemier G., Verhoef C., Mieog J.S.D., Derksen W.J.M., Van den Boezem P.B., et al. Defining Textbook Outcome in liver surgery and assessment of hospital variation: A nationwide population-based study. Eur. J. Surg. Oncol. 2022;48:2414–2423. doi: 10.1016/j.ejso.2022.06.012.
    1. Van den Broek M.A., Van Dam R.M., Van Breukelen G.J., Bemelmans M.H., Oussoultzoglou E., Pessaux P., Dejong C.H., Freemantle N., Olde Damink S.W. Development of a composite endpoint for randomized controlled trials in liver surgery. Br. J. Surg. 2011;98:1138–1145. doi: 10.1002/bjs.7503.
    1. Le Souder E.B., Azin A., Hirpara D.H., Walker R., Cleary S., Quereshy F. Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model. J. Surg. Oncol. 2018;117:1376–1385. doi: 10.1002/jso.25020.
    1. Ejaz A., Semenov E., Spolverato G., Kim Y., Tanner D., Hundt J., Pawlik T.M. Synchronous primary colorectal and liver metastasis: Impact of operative approach on clinical outcomes and hospital charges. HPB. 2014;16:1117–1126. doi: 10.1111/hpb.12302.
    1. Ecker B.L., Lee J., Saadat L.V., Aparicio T., Buisman F.E., Balachandran V.P., Drebin J.A., Hasegawa K., Jarnagin W.R., Kemeny N.E., et al. Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: A retrospective study and meta-analysis. Lancet Oncol. 2022;23:1332–1342. doi: 10.1016/S1470-2045(22)00506-X.
    1. Chan A.K., Ignatowicz A.M., Mason J.M., Siriwardena A.K. Colorectal cancer and synchronous liver metastases: An individual case-based qualitative study (CoSMIC-Q) Eur. J. Surg. Oncol. 2022;48:1815–1822. doi: 10.1016/j.ejso.2022.04.008.
    1. Soreide K. Time to halt perioperative chemotherapy for resectable colorectal liver metastasis? Br. J. Surg. 2022;109:242–243. doi: 10.1093/bjs/znab425.
    1. Soreide K., Watson M.M., Hagland H.R. Deciphering the Molecular Code to Colorectal Liver Metastasis Biology Through Microsatellite Alterations and Allelic Loss: The Good, the Bad, and the Ugly. Gastroenterology. 2016;150:811–814. doi: 10.1053/j.gastro.2016.02.060.
    1. PelvEx Collaborative Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: Results from the PelvEx Collaborative. Colorectal. Dis. 2020;22:1184–1188. doi: 10.1111/codi.15007.
    1. PelvEx Collaborative Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: Results from the PelvEx Collaborative. Colorectal. Dis. 2020;22:1258–1262. doi: 10.1111/codi.15064.
    1. Fossum C.C., Alabbad J.Y., Romak L.B., Hallemeier C.L., Haddock M.G., Huebner M., Dozois E.J., Larson D.W. The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis. J. Gastrointest. Oncol. 2017;8:650–658. doi: 10.21037/jgo.2017.06.07.
    1. Silberhumer G.R., Paty P.B., Temple L.K., Araujo R.L., Denton B., Gonen M., Nash G.M., Allen P.J., DeMatteo R.P., Guillem J., et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am. J. Surg. 2015;209:935–942. doi: 10.1016/j.amjsurg.2014.09.024.
    1. Chan A.K.C., Siriwardena A.K. Practical Implications of KRAS Mutation Status and Sidedness of Primary Tumour in Patients with Colorectal Cancer and Synchronous Liver Metastases: A Subset Analysis of the CoSMIC Study. Cancers. 2022;14:4833. doi: 10.3390/cancers14194833.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe